GUARDANT HEALTH INC (GH) Fundamental Analysis & Valuation

NASDAQ:GH • US40131M1099

Current stock price

87.18 USD
+1.69 (+1.98%)
At close:
87.18 USD
0 (0%)
After Hours:

This GH fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. GH Profitability Analysis

1.1 Basic Checks

  • In the past year GH has reported negative net income.
  • In the past year GH has reported a negative cash flow from operations.
  • GH had negative earnings in each of the past 5 years.
  • In the past 5 years GH always reported negative operating cash flow.
GH Yearly Net Income VS EBIT VS OCF VS FCFGH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -200M -400M -600M

1.2 Ratios

  • With a Return On Assets value of -20.67%, GH is not doing good in the industry: 81.19% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -20.67%
ROE N/A
ROIC N/A
ROA(3y)-25.63%
ROA(5y)-27.19%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GH Yearly ROA, ROE, ROICGH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -500 -1K

1.3 Margins

  • GH's Gross Margin of 64.46% is amongst the best of the industry. GH outperforms 84.16% of its industry peers.
  • GH's Gross Margin has been stable in the last couple of years.
  • GH does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 64.46%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.47%
GM growth 5Y-0.99%
GH Yearly Profit, Operating, Gross MarginsGH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100 -150

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. GH Health Analysis

2.1 Basic Checks

  • GH does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for GH has been increased compared to 1 year ago.
  • Compared to 5 years ago, GH has more shares outstanding
  • Compared to 1 year ago, GH has an improved debt to assets ratio.
GH Yearly Shares OutstandingGH Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
GH Yearly Total Debt VS Total AssetsGH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.2 Solvency

  • Based on the Altman-Z score of 1.57, we must say that GH is in the distress zone and has some risk of bankruptcy.
  • GH has a Altman-Z score of 1.57. This is comparable to the rest of the industry: GH outperforms 43.56% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 1.57
ROIC/WACCN/A
WACC8.02%
GH Yearly LT Debt VS Equity VS FCFGH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B

2.3 Liquidity

  • GH has a Current Ratio of 4.84. This indicates that GH is financially healthy and has no problem in meeting its short term obligations.
  • GH's Current ratio of 4.84 is amongst the best of the industry. GH outperforms 92.08% of its industry peers.
  • GH has a Quick Ratio of 4.56. This indicates that GH is financially healthy and has no problem in meeting its short term obligations.
  • GH has a better Quick ratio (4.56) than 92.08% of its industry peers.
Industry RankSector Rank
Current Ratio 4.84
Quick Ratio 4.56
GH Yearly Current Assets VS Current LiabilitesGH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. GH Growth Analysis

3.1 Past

  • The Earnings Per Share has been growing slightly by 5.62% over the past year.
  • Looking at the last year, GH shows a very strong growth in Revenue. The Revenue has grown by 32.88%.
  • Measured over the past years, GH shows a very strong growth in Revenue. The Revenue has been growing by 27.92% on average per year.
EPS 1Y (TTM)5.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-11.11%
Revenue 1Y (TTM)32.88%
Revenue growth 3Y29.76%
Revenue growth 5Y27.92%
Sales Q2Q%39.37%

3.2 Future

  • GH is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 26.17% yearly.
  • GH is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 26.92% yearly.
EPS Next Y17.14%
EPS Next 2Y20.22%
EPS Next 3Y24.13%
EPS Next 5Y26.17%
Revenue Next Year31%
Revenue Next 2Y29.77%
Revenue Next 3Y28.81%
Revenue Next 5Y26.92%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
GH Yearly Revenue VS EstimatesGH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 1B 2B 3B 4B
GH Yearly EPS VS EstimatesGH Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 5 -5

More info and screens

Find the best growth stocksShow best growing peers

1

4. GH Valuation Analysis

4.1 Price/Earnings Ratio

  • GH reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for GH. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GH Price Earnings VS Forward Price EarningsGH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GH Per share dataGH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6

4.3 Compensation for Growth

  • A more expensive valuation may be justified as GH's earnings are expected to grow with 24.13% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y20.22%
EPS Next 3Y24.13%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. GH Dividend Analysis

5.1 Amount

  • GH does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

GH Fundamentals: All Metrics, Ratios and Statistics

GUARDANT HEALTH INC

NASDAQ:GH (3/16/2026, 8:00:00 PM)

After market: 87.18 0 (0%)

87.18

+1.69 (+1.98%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-19
Earnings (Next)04-28
Inst Owners100.86%
Inst Owner Change6.01%
Ins Owners3.99%
Ins Owner Change-0.25%
Market Cap11.44B
Revenue(TTM)982.02M
Net Income(TTM)-416.28M
Analysts85.88
Price Target131.82 (51.2%)
Short Float %8.72%
Short Ratio5.37
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-20.41%
Min EPS beat(2)-38.56%
Max EPS beat(2)-2.26%
EPS beat(4)0
Avg EPS beat(4)-10.51%
Min EPS beat(4)-38.56%
Max EPS beat(4)-0.34%
EPS beat(8)0
Avg EPS beat(8)-11.47%
EPS beat(12)4
Avg EPS beat(12)0.71%
EPS beat(16)6
Avg EPS beat(16)-0.16%
Revenue beat(2)2
Avg Revenue beat(2)5%
Min Revenue beat(2)0.76%
Max Revenue beat(2)9.24%
Revenue beat(4)4
Avg Revenue beat(4)5.15%
Min Revenue beat(4)0.76%
Max Revenue beat(4)9.24%
Revenue beat(8)8
Avg Revenue beat(8)5.73%
Revenue beat(12)12
Avg Revenue beat(12)4.71%
Revenue beat(16)13
Avg Revenue beat(16)3.19%
PT rev (1m)6.95%
PT rev (3m)30.87%
EPS NQ rev (1m)-13.45%
EPS NQ rev (3m)-22.41%
EPS NY rev (1m)-11.03%
EPS NY rev (3m)-26.17%
Revenue NQ rev (1m)2.85%
Revenue NQ rev (3m)3.25%
Revenue NY rev (1m)2.91%
Revenue NY rev (3m)4.05%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 11.64
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-3.36
EYN/A
EPS(NY)-2.78
Fwd EYN/A
FCF(TTM)-1.78
FCFYN/A
OCF(TTM)-1.41
OCFYN/A
SpS7.49
BVpS-0.76
TBVpS-1.54
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -20.67%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 64.46%
FCFM N/A
ROA(3y)-25.63%
ROA(5y)-27.19%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.47%
GM growth 5Y-0.99%
F-Score5
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 121.57%
Cap/Sales 4.92%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.84
Quick Ratio 4.56
Altman-Z 1.57
F-Score5
WACC8.02%
ROIC/WACCN/A
Cap/Depr(3y)84.04%
Cap/Depr(5y)160.9%
Cap/Sales(3y)4.43%
Cap/Sales(5y)10.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)5.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-11.11%
EPS Next Y17.14%
EPS Next 2Y20.22%
EPS Next 3Y24.13%
EPS Next 5Y26.17%
Revenue 1Y (TTM)32.88%
Revenue growth 3Y29.76%
Revenue growth 5Y27.92%
Sales Q2Q%39.37%
Revenue Next Year31%
Revenue Next 2Y29.77%
Revenue Next 3Y28.81%
Revenue Next 5Y26.92%
EBIT growth 1Y1.59%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year52.61%
EBIT Next 3Y33.25%
EBIT Next 5Y29.86%
FCF growth 1Y15.23%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y22.97%
OCF growth 3YN/A
OCF growth 5YN/A

GUARDANT HEALTH INC / GH Fundamental Analysis FAQ

What is the ChartMill fundamental rating of GUARDANT HEALTH INC (GH) stock?

ChartMill assigns a fundamental rating of 3 / 10 to GH.


What is the valuation status for GH stock?

ChartMill assigns a valuation rating of 1 / 10 to GUARDANT HEALTH INC (GH). This can be considered as Overvalued.


What is the profitability of GH stock?

GUARDANT HEALTH INC (GH) has a profitability rating of 1 / 10.


Can you provide the financial health for GH stock?

The financial health rating of GUARDANT HEALTH INC (GH) is 4 / 10.